WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
South China to experience above average rainfall in May 2024
Man United's ENTIRE squad 'is up for sale'
Shooting after prom kills 1 and injures 3 in south Georgia town
Western Hemisphere nations pledge to continue coordinating response to historic regional migration
Vicky McClure cuts a stylish figure in a red velvet suit as she and co
Mets ace Kodai Senga faces hitters for the first time since his shoulder injury
Fallacies and facts about China's overcapacity
Ancient town anticipates facelift through cooperation
LIV Golf star Kevin Na unleashes foul